Clearbridge Investments LLC reduced its holdings in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) by 3.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,625,984 shares of the company’s stock after selling 85,726 shares during the quarter. Clearbridge Investments LLC’s holdings in Docusign were worth $179,617,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Central Pacific Bank Trust Division bought a new stake in Docusign during the fourth quarter worth $25,000. Modus Advisors LLC bought a new stake in Docusign during the fourth quarter worth $27,000. Torren Management LLC bought a new stake in Docusign during the fourth quarter worth $28,000. Aventura Private Wealth LLC bought a new stake in shares of Docusign in the fourth quarter valued at $30,000. Finally, True Wealth Design LLC raised its stake in shares of Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after buying an additional 222 shares during the period. 77.64% of the stock is currently owned by institutional investors.
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: DocuSign beat first-quarter expectations, posting adjusted EPS of $1.09 versus $1.00 expected and revenue of $830.2 million versus $823.2 million estimated, with sales up 8.7% year over year. DocuSign Beats Fiscal Q1 Estimates, but IAM Traction Remains in Focus, RBC Says
- Positive Sentiment: The company said adoption of its AI-powered Intelligent Agreement Management platform is improving, and it raised full-year revenue guidance slightly, indicating demand remains healthy. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
- Neutral Sentiment: Analyst commentary remains mixed, with Wedbush lowering its price target to $58 from $60 while keeping a neutral rating, and BTIG cutting its target to $60 from $70 but maintaining a buy rating.
- Neutral Sentiment: DocuSign also highlighted AI integrations, including ChatGPT and Codex, and continued share repurchases, which support the long-term story but were not enough to offset near-term guidance concerns. Docusign Inc (DOCU) Q1 2027 Earnings Call Highlights
- Negative Sentiment: Shares moved lower because the full-year outlook did not meaningfully exceed Wall Street expectations, dampening enthusiasm despite the earnings beat and prompting a “sell-the-news” reaction. DocuSign shares fall despite Q1 beat as guidance disappoints investors
- Negative Sentiment: Investors also appear to be focusing on whether DocuSign can accelerate growth beyond the low-double-digit range, as recent reports say the outlook “left investors looking for stronger signs of accelerating growth.” DocuSign stock falls as cautious outlook overshadows earnings beat
Insider Buying and Selling at Docusign
Docusign Price Performance
Docusign stock opened at $47.26 on Monday. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $86.65. The business has a 50-day simple moving average of $47.76 and a 200 day simple moving average of $54.09. The stock has a market cap of $9.18 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 1.80 and a beta of 0.92.
Docusign (NASDAQ:DOCU – Get Free Report) last posted its earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business had revenue of $830.24 million during the quarter, compared to analysts’ expectations of $824.71 million. During the same period in the previous year, the business earned $0.90 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. On average, research analysts anticipate that Docusign Inc. will post 1.76 earnings per share for the current year.
Docusign declared that its board has initiated a share repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to repurchase up to 21% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s management believes its shares are undervalued.
Analyst Ratings Changes
DOCU has been the topic of several research reports. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday. Morgan Stanley lowered their target price on Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 18th. Citizens Jmp lowered their target price on Docusign from $124.00 to $86.00 and set a “market outperform” rating on the stock in a research note on Wednesday, March 18th. Royal Bank Of Canada reduced their price target on Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research report on Wednesday, March 18th. Finally, Robert W. Baird reduced their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $60.27.
Check Out Our Latest Research Report on Docusign
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
